Compare Axon Enterprise Inc (AXON) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axon Enterprise Inc vs BIO-TECHNE Corp — how do they compare? Axon Enterprise Inc trades at $550 (market cap $44.09B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Axon Enterprise Inc is far larger — about 4× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Axon Enterprise Inc pays none. Which is the better fit depends on your goals.
| AXON | TECH | |
|---|---|---|
Market Cap | $44.09B | $11.12B |
Sector | Technology | Health |
52-Week High | $870.97 | $71.38 |
52-Week Low | $345.94 | $43.31 |
Enterprise Value | $45.18B | $11.20B |
Dividend Yield | — | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Axon Enterprise Inc
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
